Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation.

Veedfald S, Plamboeck A, Hartmann B, Svendsen LB, Vilsbøll T, Knop FK, Holst JJ.

Peptides. 2015 Jul 25. pii: S0196-9781(15)00216-8. doi: 10.1016/j.peptides.2015.07.020. [Epub ahead of print]

PMID:
26218807
2.

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.

Rhee NA, Wahlgren CD, Pedersen J, Mortensen B, Langholz E, Wandall EP, Friis SU, Vilmann P, Paulsen SJ, Kristiansen VB, Jelsing J, Dalbøge LS, Poulsen SS, Holst JJ, Vilsbøll T, Knop FK.

Diabetologia. 2015 Jul 18. [Epub ahead of print]

PMID:
26186884
3.

Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.

Gyldenløve M, Vilsbøll T, Zachariae C, Holst JJ, Knop FK, Skov L.

J Intern Med. 2015 Jul 14. doi: 10.1111/joim.12388. [Epub ahead of print]

PMID:
26174490
4.

Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.

Brønden A, Naver SV, Knop FK, Christensen M.

Expert Opin Drug Metab Toxicol. 2015 Jul 13:1-11. [Epub ahead of print]

PMID:
26166682
5.

Retinal vascular and structural dynamics during acute hyperglycaemia.

Klefter ON, Vilsbøll T, Knop FK, Larsen M.

Acta Ophthalmol. 2015 Jul 6. doi: 10.1111/aos.12797. [Epub ahead of print]

PMID:
26146858
6.

The Role of Efferent Cholinergic Transmission for the Insulinotropic and Glucagonostatic Effects of GLP-1.

Plamboeck A, Veedfald S, Deacon CF, Hartmann B, Vilsboll T, Knop FK, Holst JJ.

Am J Physiol Regul Integr Comp Physiol. 2015 Jul 1:ajpregu.00123.2015. doi: 10.1152/ajpregu.00123.2015. [Epub ahead of print]

PMID:
26136531
7.

Premature explantation of an EndoBarrier gastrointestinal liner because of sleeve invagination.

Rohde U, Federspiel CA, Vilmann P, Friis SU, Langholz E, Vilsbøll T, Knop FK.

Endoscopy. 2015;47 Suppl 1:E275-6. doi: 10.1055/s-0034-1391906. Epub 2015 Jun 22. No abstract available.

PMID:
26099090
8.

Postprandial prolactin suppression appears absent in antipsychotic-treated male patients.

Coello K, Broberg BV, Bak N, Madsen A, Mortensen HB, Søgaard B, Szecsi PB, Knop FK, Lublin H, Ebdrup BH.

Psychoneuroendocrinology. 2015 Jun 6;60:1-6. doi: 10.1016/j.psyneuen.2015.05.014. [Epub ahead of print]

9.

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.

Østoft SH, Bagger JI, Hansen T, Hartmann B, Pedersen O, Holst JJ, Knop FK, Vilsbøll T.

Eur J Endocrinol. 2015 Aug;173(2):205-15. doi: 10.1530/EJE-15-0070. Epub 2015 May 7.

PMID:
25953829
10.

Pancreatic Amylase and Lipase Plasma Concentrations Are Unaffected by Increments in Endogenous GLP-1 Levels Following Liquid Meal Tests.

Sonne DP, Vilsbøll T, Knop FK.

Diabetes Care. 2015 May;38(5):e71-2. doi: 10.2337/dc14-2751. No abstract available.

PMID:
25908158
11.

Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.

Junker AE, Gluud LL, Holst JJ, Knop FK, Vilsbøll T.

J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12981. [Epub ahead of print]

PMID:
25867498
12.

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.

Dejgaard TF, Knop FK, Tarnow L, Frandsen CS, Hansen TS, Almdal T, Holst JJ, Madsbad S, Andersen HU.

BMJ Open. 2015 Apr 2;5(4):e007791. doi: 10.1136/bmjopen-2015-007791.

13.

Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis.

Gyldenløve M, Vilsbøll T, Holst JJ, Zachariae C, Skov L, Knop FK.

Br J Dermatol. 2015 Mar 27. doi: 10.1111/bjd.13789. [Epub ahead of print]

PMID:
25819574
14.

Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide.

Vedtofte L, Knop FK, Vilsbøll T.

Expert Rev Clin Pharmacol. 2015 May;8(3):273-82. doi: 10.1586/17512433.2015.1029455. Epub 2015 Mar 30.

PMID:
25816888
15.

Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.

Novaes FS, Vasques AC, Pareja JC, Knop FK, Tura A, Chaim ÉA, Geloneze B.

J Clin Endocrinol Metab. 2015 May;100(5):1984-8. doi: 10.1210/jc.2014-4042. Epub 2015 Mar 5.

PMID:
25742514
16.

Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study.

Schopman JE, Hoekstra JB, Frier BM, Ackermans MT, de Sonnaville JJ, Stades AM, Zwertbroek R, Hartmann B, Holst JJ, Knop FK, Holleman F.

Diabetes Obes Metab. 2015 Jun;17(6):546-53. doi: 10.1111/dom.12453. Epub 2015 Mar 24.

PMID:
25694217
17.

Patients with psoriasis are insulin resistant.

Gyldenløve M, Storgaard H, Holst JJ, Vilsbøll T, Knop FK, Skov L.

J Am Acad Dermatol. 2015 Apr;72(4):599-605. doi: 10.1016/j.jaad.2015.01.004. Epub 2015 Feb 1.

PMID:
25653028
18.

A 25-year-old woman with type 2 diabetes and liver disease.

Junker AE, Gluud LL, Pedersen J, Langhoff JL, Holst JJ, Knop FK, Vilsbøll T.

Case Rep Gastroenterol. 2014 Dec 12;8(3):398-403. doi: 10.1159/000369968. eCollection 2014 Sep-Dec.

19.
20.

Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.

Chalmer T, Almdal TP, Vilsbøll T, Knop FK.

Expert Opin Drug Saf. 2015 Jan;14(1):171-80. doi: 10.1517/14740338.2015.975205. Epub 2014 Nov 3.

PMID:
25363438
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk